Computational Fluid Dynamics (CFD) Modeling for Cardiovascular Devices

The contract requires the execution of high-fidelity computational fluid dynamics simulations to analyze blood flow through cardiovascular devices such as stents and valves under realistic physiological conditions. The work demands advanced numerical modeling capabilities to accurately capture hemodynamic behavior, including pressure gradients, wall shear stress, and turbulent flow patterns that impact device performance and biological response. The scope is focused on delivering precise, validated simulation results that support regulatory evaluation and design optimization of medical devices within the cardiovascular space. The opportunity is listed as a subcontract under NAICS code 541620 and is issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. The solicitation was posted on July 28, 2026, with a response deadline of August 7, 2026. While no specific place of performance or point of contact is provided, the nature of the work suggests collaboration with regulatory and biomedical engineering teams to ensure simulation outputs meet FDA standards for safety and efficacy. Interested parties must demonstrate technical expertise in CFD, experience with biomedical applications, and the ability to deliver robust, reproducible results within the stated timeline.